Csenge Advisory Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Csenge Advisory Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.35M	Buy	+31,620	New	+$6.54M	0.29%	68
2025 Q2	–	Sell	-54,039	Closed	-$8.23M	–	692
2025 Q1	$8.23M	Buy	54,039 +2,304	+4%	+$400K	0.47%	42
2024 Q4	$8.6M	Buy	51,735 +988	+2%	+$169K	0.47%	39
2024 Q3	$8.74M	Buy	50,747 +5,320	+12%	+$881K	0.46%	42
2024 Q2	$7M	Buy	45,427 +26,703	+143%	+$4.01M	0.4%	45
2024 Q1	$2.88M	Sell	18,724 -1,455	-7%	-$222K	0.16%	114
2023 Q4	$3.19M	Buy	20,179 +283	+1%	+$40.7K	0.2%	92
2023 Q3	$2.91M	Buy	19,896 +964	+5%	+$147K	0.2%	95
2023 Q2	$2.9M	Buy	18,932 +5,609	+42%	+$875K	0.19%	100
2023 Q1	$2.07M	Buy	13,323 +9,376	+238%	+$1.47M	0.15%	125
2022 Q4	$608K	Buy	+3,947	New	+$582K	0.05%	300
2020 Q3	–	Sell	-10,292	Closed	-$1.73M	–	406
2020 Q2	$1.73M	Buy	+10,292	New	+$1.62M	0.25%	77

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Csenge Advisory Group's FBT Position: Q1 2026 in Review

Csenge Advisory Group opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026: 31,620 shares worth $6.35M. The stake represents 0.29% of the portfolio and ranks #68 among its holdings. This is a return to the name: Csenge Advisory Group previously reported a position in FBT as recently as Q1 2025.

Csenge Advisory Group first reported a position in FBT in Q2 2020 and has held it in 12 quarters since. The position peaked at $8.74M in Q3 2024. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Csenge Advisory Group held 31,620 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.35M as of Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Csenge Advisory Group position in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.29% of Csenge Advisory Group's portfolio in Q1 2026, its #68 holding.
Csenge Advisory Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 12 quarters since.
Csenge Advisory Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $8.74M in Q3 2024.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.